Ongoing Phase II Pancreatic Cancer Trial Metabolic therapy is tumor-treating, patient-sparing - 102337

Spotlight
Video

Ongoing Phase II Pancreatic Cancer Trial Metabolic therapy is tumor-treating, patient-sparing

Loading........
Description: Jon Eckard, PhD, TYME Inc., explains Ongoing Phase II Pancreatic Cancer Trial Metabolic therapy is tumor-treating, patient-sparing at Annual Meeting 2018.
Shared By : Annual-Meeting
Posted on : 06/06/18
Added : 12 months ago
Category : Pancreatic Cancer

Tags: patient